ArticleMolecular and clinical oncology2025

Benefits of neoadjuvant chemotherapy with gemcitabine plus S-1 for resectable pancreatic ductal adenocarcinoma.

Teijiro Hirashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.